Research Article Asian Journal of Pharmaceutical and Clinical Research LAMIVUDINE LOADED MICROSPHERES FOR ORAL USE: DESIGN, DEVELOPMENT AND ESTABLISHMENT OF INVIVO-INVITRO CORRELATION *1

Source URL: ajpcr.com

• Microbiology
• Microsphere
• Scales
• Drug delivery
• Time release technology
• Lamivudine
• Biopharmaceutics Classification System
• Bioequivalence
• Pharmacology
• Pharmaceutical sciences
• Medicine

ViiV Healthcare Receives EU marketing authorization for Triumeq®, a Single-pill Regimen Containing the Integrase Inhibitor “Dolutegravir” Osaka, Japan, September 4, Shionogi & Co., Ltd. (Head Office: Osaka; P

Source URL: shionogi616.tew-staging.com

• Integrase inhibitors
• Abacavir
• Cyclopropanes
• Purines
• Antiretroviral drug
• HIV/AIDS
• Lamivudine
• Reverse-transcriptase inhibitor
• ViiV Healthcare
• Biology
• Chemistry
• Organofluorides

Shionogi-ViiV Healthcare LLC Initiates Phase III Clinical Programme for Investigational Once-Daily HIV Integrase Inhibitor Phase III Treatment-naïve and Treatment-experienced Trials Underway for S/GSK1349572 (‘572)

Source URL: shionogi616.tew-staging.com

• Health
• Medicine
• Integrase inhibitors
• GlaxoSmithKline
• ViiV Healthcare
• Lamivudine
• Pfizer
• Integrase
• Raltegravir
• Organofluorides
• Chemistry
• HIV/AIDS

Shionogi-ViiV Healthcare Starts Phase III Trial for “572-Trii” Fixed-Dose Combination HIV Therapy London, UK, 3 February 2011 – Shionogi-ViiV Healthcare, LLC announced today that the first patient has entered the c

Source URL: shionogi616.tew-staging.com

• Organic chemistry
• Organofluorides
• Gilead Sciences
• Cyclopropanes
• Purines
• Abacavir/lamivudine
• Abacavir
• Lamivudine
• Fixed-dose combination
• Medicine
• Chemistry
• Fixed dose combination

EXHIBIT 2 Ndc Name Dosage Strength Pkg. Size

Source URL: health.tn.gov

• NOS
• Food and drink
• Chemistry
• Lamivudine
• Organofluorides
• Tab

ISENTRESS ™(raltegravir), in Combination with tenofovir /lamivudine, Showed Durable and Potent Antiretroviral Activity in Treatment Naïve, HIV-1 Infected Patients, with Similar HIV RNA Reduction to Efavirenz in Combin

Source URL: www.msd-italia.it

Shionogi-ViiV Healthcare announces positive initial data from phase III study of dolutegravir-based regimen vs Atripla in HIV London, United Kingdom, 11 July 2012: Shionogi-ViiV Healthcare LLC today announced that initia

Source URL: shionogi616.tew-staging.com

• Organofluorides
• Medicine
• Fixed dose combination
• Bristol-Myers Squibb
• Cyclopropanes
• Emtricitabine/tenofovir/efavirenz
• Antiretroviral drug
• Abacavir
• Lamivudine
• Chemistry
• Pharmacology
• Gilead Sciences

Poster WEPE048 Prevalence of chronic hepatitis B virus infection among HIV-infected children in northern Namibia; using baseline ALT<2 x ULN as an indicator of immune tolerant phase of chronic HBV infection and purposef

Source URL: www.go2itech.org

• Microbiology
• Viral structural proteins
• Organofluorides
• Gilead Sciences
• Hepatitis B
• Lamivudine
• HBcAg
• HBsAg
• Reverse-transcriptase inhibitor
• Purines
• Health
• Medicine

research Managing chronic hepatitis B The role of the GP Jack Wallace Behzad Hajarizadeh

Source URL: www.racgp.org.au

• Hepatitis
• General practice
• General practitioner
• Hepatocellular carcinoma
• Hepatitis B
• Viral hepatitis
• Primary care physician
• Lamivudine
• Methadone
• Medicine
• Health
• Hepatology

Entecavir and Hepatitis B Background on Hepatitis B Hepatitis B virus (HBV) is highly endemic in South Africa and across sub-Saharan Africa, where around 8% of people are chronically infected, and rates of HBV-related li

Source URL: www.fixthepatentlaws.org

• Purines
• Viral hepatitis
• Hepatitis B
• Lamivudine
• Hepatitis C
• Hepatocellular carcinoma
• Viral disease
• HBsAg
• Evergreening
• Medicine
• Bristol-Myers Squibb
• Entecavir